Update on procalcitonin measurements

Annals of Laboratory Medicine

Volumn 34, Issue 4, 2014, Pages 263-273

  Meisner, Michael ^a  

^a Medizinische Klinik   (Germany)

Author keywords

Anti bacterial agents; Critical illness; Intensive care units; Procalcitonin; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

BACTERIAL INFECTIONS; COMPLICATION; HUMAN; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; HUMANS; PROTEIN PRECURSORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 84904416980     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2014.34.4.263     Document Type: Review

References (105)

1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96. (Pubitemid 43810035)
2. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guideline for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
3. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised control trial. Lancet 2010;375:463-74.
4. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, et al. Procalcitonin for reduced antibiotic exposure in ventilator associated pneumonia: a randomised stury. Eur Respir J 2009;34:1364-75.
5. Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, et al. Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy. Anaesthesist 2008;57:571-7.
6. Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009;394:221-6.
7. Qu R, JiY, Ling Y, Ye CY, Yang SM, Liu YY, et al. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial. Saudi Med J 2012;33:382-7.
8. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008;168:2000-7.
9. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Müller C, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007;131:9-19. (Pubitemid 46122969)
10. Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, et al. Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen (akute Bronchitis, akute Exazerbation einer chronischen Bronchitis, Influenza und andere respiratorische Virusinfektionen) sowie ambulant erworbener Pneumonie. Pneumonologie. 2009; 63:e1-68.
11. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci 2010;8:1-86.
12. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohoun C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8. (Pubitemid 23066085)
13. Linscheid P, Seboek D, Schaer JD, Zulewski H, Keller U, Müller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and macrophage-activated adipocytes. Crit Care Med 2004;32:1715-21. (Pubitemid 39050523)
14. Meisner M, Müller V, Khakpour Z, Toegel E, Redl H. Induction of procalcitonin and proinflammatory cytokines in an anheptic baboon endotoxin shock model. Shock 2003;19:187-90.
15. Wiedermann FJ, Kaneider N, Egger P, Tiefenthaler W, Wiedermann CJ, Lindner KH, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002;30:1112-7. (Pubitemid 34508036)
16. Hoffmann G, Totzke G, Seibel M, Smolny M, Wiedermann FJ, Schobersberger W. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med 2001;29:112-6. (Pubitemid 32125783)
17. Hoffmann G, Czechowski M, Schloesser M, Schobersberger W. Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002;30:2091-5.
18. Müller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001;131:595-602. (Pubitemid 34044981)
19. Wrenger S, Kähne T, Bohuon C, Weglöhner W, Ansorge S, Reinhold D. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). FEBS Lett 2000;466:155-9. (Pubitemid 30050703)
20. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:R234-42.
21. Ugarte H, Silva E, Mercan D, De Mendonça A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504. (Pubitemid 29162669)
22. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003. (Pubitemid 43982479)
23. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998;24:680-4. (Pubitemid 28393399)
24. Clech C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004;32:1166-9. (Pubitemid 38620986)
25. van Langevelde P, Joop K, van Loon J, Frölich M, Groeneveld PH, Westendorp RG, et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000;31:1343-8.
26. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro. J Lab Clin Med 1999;134:49-55. (Pubitemid 29332170)
27. Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013;75:342-7.
28. Pfister R, Kochanek M, Leygeber T, Brun-Buisson C, Cuquemelle E, Paiva Machado MB, et al. Procalcitonin for diagnosis of bacterial pneumonia in critically illpatients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care 2014;18:R44.
29. Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, et al. Measurement of procalcitonin levels in children with bacterial and viral meningitis. Clin Infect Dis1997;24:1240-2. (Pubitemid 27249031)
30. Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001;84:332-6. (Pubitemid 32328629)
31. Mathew B, Roy DD, Kumar TV. The use of procalcitonin as a marker of sepsis in children. J Clin Diagn Res 2013;7:305-7.
32. Festic E, Siegel J, Stritt M, Freeman WD. The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2014;2 [Epub ahead of print].
33. Peters RP, Twisk JW, van Agtmael MA, Groeneveld AB. The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients. Clin Microbiol Infect 2006;12:1207-13. (Pubitemid 44762523)
34. Liaudat S, Dayer E, Praz G, Bille J, Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001;20:524-7. (Pubitemid 32905527)
35. vanNieuwkoop C, Bonten TN, van Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010;14:R206.
36. Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, Georgitsi M, Raftogiannis M, Antonakos N, et al. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care 2011;26.e1-7.
37. Kylänpää-Bäck ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, Repo H. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001;88:222-7. (Pubitemid 32142709)
38. Rau B, Kemppainen EA, Gumbs AA, Büchler MW, Wegscheider K, Bassi C, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 2007;245:745-54. (Pubitemid 46684104)
39. Kylänpää-Bäck ML, Takala A, Kamppainen EA, Puolakkainen PA, Leppäniemi AK, Karonen SL, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29:63-9. (Pubitemid 32125776)
40. Magrini L, Travaglino F, Marino R, Ferri E, De Berardinis B, Cardelli P, et al. Procalcitonin variations after emergency department admission are highly predictive of hospital mortality in patients with acute infectious disease. Eur Rev Med Pharmacol Sci 2013;17(S1):S113-42.
41. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006;10:R125.
42. Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000;28:2591-4. (Pubitemid 30604475)
43. Friederichs J, Hutter M, Hierholzer C, Novotny A, Friess H, Bühren V, et al. Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections. Am J Surg 2013;206:368-73.
44. Meisner M, Lohs T, Huttemann E, Schmidt J, Huller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001;18:79-87. (Pubitemid 32158262)
45. Wojciechowicz KH, Hoffkamp HJ, van Hulst RA. Conservative treatment of acute appendicitis: an overview. Int Marit Health 2010;62:265-72.
46. Ansaloni L, Catena F, Coccolini F, Ercolani G, Gazotti F, Pasqualini E, et al. Surgery versus conservative antibiotic treatment in acute appendicitiis: a systematic review and meta-analysis of randomized controlled trials. Dig Surg 2011;28:210-21.
47. Chandel V, Batt SH, Bhat MY, Kawoosa NU, Yousuf A, Zargar BR. Procalcitonin as the biomarker of inflammation in diagnosis of appendicitis in pediatric patients and prevention of unneccesary appendectomies. Indian J Surg 2011;73:136-41.
48. Wu JY, Chen HC, Lee SH, Chan RC, Lee CC, Chang SS. Diagnostic role of procalcitonin in patients with suspected appendicitis. Word J Surg 2012;36:1774-9.
49. Kafetzis DA, Velissariou IM, Nikolaides P, Sklavos M, Maktabi M, Spyridis G, et al. Procalcitonin as a predictor of severe appendicitis in children. Eur J Clin Microbiol Infect Dis 2005;24:484-7. (Pubitemid 41124502)
50. Yu CW, Juan LI, Wu MH, Shen CJ, Wu JY, Lee CC. Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis. Br J Surg 2013;100:322-9.
51. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. JAMA 2009;302:1059-66.
52. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177:498-505. (Pubitemid 351442188)
53. Gibot S. Procalcitonin in intensive care units: the PRORATA trial. Lancet 2010;375:1605-6.
54. Tarnow-Mordi W and Gebski V. Procalcitonin in intensive care units: the PRORATA trial. Lancet 2010;375:1605.
55. Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, et al. Procalcitonin to initiate or discontinue antibiotiics in acute respiratory tract infections. Evid Based Child Health 2013;8:1297-371.
56. Wilke MH, Grube RF, Bodmann KF. The use of standardized PCT-algorithm reduces costs in intensive care in septic patients-a DRG-based simulation model. Eur J Med Res 2011;16:543-8.
57. Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012;172:715-22.
58. Kook JL, Chao SR, Le J, Robinson PA. Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital. Infect Control Hosp Epidemiol 2012;33:424-6.
59. Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop Antibiotics on guidance of Procalcitonin study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients-caluculated sample size: 1816 patients. BMC Infect Dis 2013;13:178.
60. Deliberato RO, Marra AR, Sanches PR, Martino MD, Ferreira CE, Pasternak J, et al. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis 2013;76:266-71.
61. Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, et al. Influence of procalcitonin on decision to start antibiotic treatment in patients with lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis 2013;32:51-60.
62. Annane D, Maxime V, Faller JP, Mezher C, Clech C, Martel P, et al. Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open 2013;3:e002186.
63. Liew YX, Lee W, Cai YY, Teo J, Tang SS, Ong RW, et al. Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies. Eur J Clin Microbiol Infect Dis 2012;31:3041-6.
64. Ding J, Chen Z, Feng K. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis. Int J Med Sci 2013;10:903-7.
65. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster- randomised, single-blinded intervention trial. Lancet 2004;363:600-7. (Pubitemid 38264177)
66. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, et al. Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174:84-93. (Pubitemid 43955248)
67. Hohn A, Schroeder S, Gehrt A, Bernhardt K, Bein B, Wegscheider K, et al. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infect Dis 2013;13:158.
68. Meisner M, Hutzler A, Tschaikowsky K, Harig F, von der Emde J. Postoperative plasma concentration of procalcitonin and C-reactive protein in patients undergoing cardiac and thoracic surgery with and without cardiopulmonary bypass. Cardiovasc Eng 1998;3:174-8. (Pubitemid 29099551)
69. Syvänen J, Peltola V, Pajulo O, Ruuskanen O, Mertsola J, Helenius I. Normal behaviour of plasma procalcitonin in adolescents undergoing surgery for scoliosis. Scand J Surg 2014;103:60-5.
70. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000;28:950-7. (Pubitemid 30262061)
71. Meisner M, Heide A, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006:10:R1.
72. vonHeimburg D, Stieghorst W, Khorram-Sefat R, Pallua N. Procalcitonin -a sepsis parameter in severe burn injuries. Burns 1998;24:745-50. (Pubitemid 29022845)
73. Lavrentieva A, Kontakiotis T, Lazaridis L, Tsotolis N, Koumis J, Kyriazis G, et al. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns 2007;33:189-94.
74. Ulrich D, Noah EM, Pallua N. Plasma endotoxin, procalcitonin, C-reaktives protein, andorgan functions in patients with major burns. Handchir Mikrochir Plast Chir 2001;33:262-6. (Pubitemid 32744071)
75. Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFa and endotoxin levels early after thermal injury. Burns 1997;23:218-24. (Pubitemid 27303043)
76. de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997;25:607-13. (Pubitemid 27193972)
77. Brunkhorst FM, Forycki ZF, Wagner J. Procalcitonin-immunoreactivity in patients with cardiogenic shock- does bacterial inflammation influence the prognosis? Eur Heart J 1996;17:S67-72.
78. Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 2003;29:1384-9. (Pubitemid 37041172)
79. Nylén ES, Al Arifi A, Becker KL, Snider RH Jr, Alzeer A. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997;25:1362-5. (Pubitemid 27347301)
80. Hausfater P, Hurtado M, Pease S, Juillien G, Lvovschi VE, Salehabadi S, et al. Is procalcitonin a marker of criticall illness in heatstroke? Intensive Care Med 2008;34:1377-83.
81. Sabat R, Höflich C, Döcke WD, Oppert M, Kern F, Windrich B, et al. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med 2001;27:987-91. (Pubitemid 32662479)
82. Abramowicz D, Schandene L, Goldmann M, Crusiaux A, Vareerstraeten P, De Pauw L, et al. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989;47:606-8. (Pubitemid 19110914)
83. Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000;26:S159-64. (Pubitemid 30186575)
84. Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. ClinExpRheumatol 2006;24:123-8. (Pubitemid 43826859)
85. Korczowski B. Serum procalcitonin concentration in children with liver disease. Pediatr Infect Dis J 2006;25:268-9. (Pubitemid 43379072)
86. Delèvaux I, André M, Colombier M, Albuisson E, Meylheuc F, Bègue RJ, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes ? Ann Rheum Dis 2003;62:337-40.
87. Scirè CA, Caporali R, Perotti C, Montecucco C. Plasma procalcitonin in rheumatic diseases. Reumatismo 2003;55:113-8.
88. Kàdàr J and Petrovicz E. Adult-onset Stills disease. Best Pract Res Clin Rheumatol 2004;18:663-76.
89. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegeners granulomatosis. J Rheumatol 1998;25:1531-3. (Pubitemid 28364758)
90. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmatic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250-6. (Pubitemid 27430136)
91. Dahaba AA, Rehak PH, List WF. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003;29:579-83. (Pubitemid 36523674)
92. Steinbach G, Bölke E, Grünert A, Störck M, Orth K. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 2004;116:849-53. (Pubitemid 40128388)
93. Meisner M, Hüttemann E, Lohs T, Kasakov L, Reinhart K. Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 2001;15:171-5. (Pubitemid 33599098)
94. Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H. Procalcitonin in patients undergoing chronic hemodialysis. Nephron 2000;84:187-8. (Pubitemid 30081571)
95. Elefsiniotis IS, Skounakis M, Vezali M, Pantazis KD, Petrocheilou A, Pirounaki M, et al. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol 2006;18:525-30. (Pubitemid 43832753)
96. Attar BM, Moore CM, George M, Ion-Nedelcu N, Turbay R, Zachariah A, et al. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014;20:2374-82.
97. Fries M, Kunz D, Gressner AM, Roissant R, Kuhlen R. Procalcitonin serum levels after ouf-of-hospital cardiac arrest. Resuscitation 2003;59:105-9. (Pubitemid 37297984)
98. Oppert M, Reinicke A, Müller C, Barckow D, Frei U, Eckard KU. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation 2002;53:167-70. (Pubitemid 34493800)
99. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998;26:664-72. (Pubitemid 28155017)
100. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 2006;91:F283-6. (Pubitemid 44031415)
101. Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 2010;97:165-74.
102. Lencot S, Cabaret B, Sauvage G, Laurans C, Launay E, Orsonneau JL, et al. A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm. Eur J Clin Microbiol Infect Dis 2014 [Epub ahead of print].
103. Jimeno A, García-Velasco A, del Val O, Gonzàlez- Billalabeitia E, Hernando S, Hernàndez R, et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 2004;100:2462-9. (Pubitemid 38657897)
104. Bihan H, Becker KL, Snider RH, Nylen E, Vittaz L, Lauret C, et al. Calcitonin precursor levels in human medullary thyroid carcinoma. Thyroid 2003;13:819-22. (Pubitemid 37070162)
105. Morgenthaler NG, Struck J, Fischer-Schulz C, Seidel-Mueller E, Beier W, Bergmann A. Detection of Procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab 2002; 48: 263-270 (Pubitemid 34619159)